The Zacks Analyst Blog Highlights: Berkshire Hathaway, Eli Lilly, T-Mobile, Oracle and Marathon Petroleum

For Immediate Release

Chicago, IL - February 16, 2017 - announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Berkshire Hathaway (NYSE: BRK.B - Free Report ), Eli Lilly (NYSE: LLY - Free Report ), T-Mobile (NASDAQ: TMUS - Free Report ), Oracle (NYSE: ORCL - Free Report ) and Marathon Petroleum (NYSE: MPC - Free Report ).

Today, Zacks is promoting its ''Buy'' stock recommendations. Get #1Stock of the Day pick for free.

Here are highlights from Wednesday's Analyst Blog:

Top Research Reports for Thursday: LLY, TMUS, BRK.B

Today's Research Daily features new research reports on 16 major stocks, including Berkshire Hathaway (NYSE: BRK.B - Free Report ), Eli Lilly (NYSE: LLY - Free Report ) and T-Mobile (NASDAQ: TMUS - Free Report ).

Berkshire Hathaway shares have modestly lagged the Zacks Finance over the past 12 months (+29.8% vs. +35.4%), but have done better than the S&P 500 index in that same time period (+29.8% vs. +22.4%). The insurance business, which remains at the core of this financial conglomerate's business portfolio, is as much a beneficiary of the post-election momentum in interest rates as are traditional banks and brokers. Berkshire Hathaway is more than insurance - it has assets in the railroads, oil pipelines and many other spaces. The company's name has long been synonymous with Warren Buffet, concerns about whose succession have been an issue for the stock. The company is expected to report fourth quarter results on Feb 24. (You can read the full research report on Berkshire Hathaway here >> )

Pharmaceutical stocks have been under pressure since last year on pricing and regulatory concerns and Eli Lily shares have been no different. That said, the stock has done modestly better than the peer group; it is up +7.6% over the last 12 months vs. +5.8% for the Zacks Pharma industry and +4.3% for the Zacks Medical sector. Lilly's fourth-quarter results were mixed with earnings missing estimates but revenues coming out ahead. But the analyst is encouraged by the fact that Lilly expects to launch 20 new products in a 10 year time-frame ranging from 2014 to 2023 and could launch at least 2 new indications/line extensions on average every year. Moreover, Lilly expects to return to annual dividend increases and to return excess cash through share buybacks. (You can read the full research report on Lilly here >> )

T-Mobile shares have been strong performers lately - the stock is up +68.1% over the last 12 months, handily outperforming the Zacks National Wireless industry (up +12.4%) and the broader Zacks Telecom Services industry (+6.9%). Driving this outperformance is the success of the carrier's cultivation of an 'insurgent' persona through promotional measures like the 'Un-carrier' initiatives. Being the fourth national carrier, the company regularly gets mentioned in industry consolidation rumors, which helps the stock price. The Zacks analyst also likes the company's network expansion plans such as 5G trials with Ericsson as well as 4G LTE network improvement and expansion. On the flip side, T-Mobile US operates in a highly competitive and saturated wireless market where it has to work hard to maintain its growth momentum. (You can read the full research report on T-Mobile here >> )

Other noteworthy reports we are featuring today include Oracle (NYSE: ORCL - Free Report ) and Marathon Petroleum (NYSE: MPC - Free Report ).

Today's Private Buys & Sells from Zacks Research

While we share the above news with the public, our sensitive recommendations are hidden from everyone but selected members. Would you like to peek behind the curtain and view them? Starting today, for the next month, you can follow all Zacks' private buys and sells in real time from value to momentum . . . from stocks under $10 to ETF and option moves . . . from insider trades to companies that are about to report positive earnings surprises (we've called them with 80%+ accuracy). You can even look inside portfolios so exclusive that they are normally closed to new investors. Click here for Zacks' secret trades >>

Today, Zacks is promoting its ''Buy'' stock recommendations. Get #1 Stock of the Day pick for free .

About Zacks Equity Research

Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.

Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.

Strong Stocks that Should Be in the News

Many are little publicized and fly under the Wall Street radar. They're virtually unknown to the general public. Yet today's 220 Zacks Rank #1 "Strong Buys" were generated by the stock-picking system that has nearly tripled the market from 1988 through 2015. Its average gain has been a stellar +26% per year. See these high-potential stocks free >>.

Get the full Report on BRK.B - FREE

Get the full Report on LLY - FREE

Get the full Report on TMUS - FREE

Get the full Report on ORCL - FREE

Get the full Report on MPC - FREE

Follow us on Twitter:

Join us on Facebook:

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

Media Contact

Zacks Investment Research

800-767-3771 ext. 9339

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit for information about the performance numbers displayed in this press release.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Berkshire Hathaway Inc. (BRK.B): Free Stock Analysis Report

Eli Lilly and Company (LLY): Free Stock Analysis Report

T-Mobile US, Inc. (TMUS): Free Stock Analysis Report

Oracle Corporation (ORCL): Free Stock Analysis Report

Marathon Petroleum Corporation (MPC): Free Stock Analysis Report

To read this article on click here.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story


Other Topics


Latest Markets Videos


    Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. In 1978, our founder discovered the power of earnings estimate revisions to enable profitable investment decisions. Today, that discovery is still the heart of the Zacks Rank. A wealth of resources for individual investors is available at

    Learn More